Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UBT37034 in Overweight/Obesity
NCT07873645Phase 1Recruiting
- Start
- Oct 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of UBT37034 in obesity (5 arms). Primary endpoints: Incidence of Adverse Events at Week 23, Change from baseline in physical examinations at Week 23 and 8 more. Started Oct 2026; status: recruiting.
02
Drugs
UBT37034
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07873645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07873645.